US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Stef (0NY3) 銘柄情報

Stef (0NY3)

110.20

0.00

(0.00%)

終了 7月5日 12:30AM

Stef (0NY3) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

110.20

( - )

買値

110.20

売値

110.20

出来高

0.00

0.00 日の範囲 0.00

110.20 52 週間の範囲 110.20

時価総額

前日終値

110.20

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

3,684 €

発行済株式数

12,649,263

配当利回り

2.7 (2.28%)

PER

17.72

1 株当たり利益 (EPS)

6.66

歳入

5.12B

純利益

84.25M

STEF SA provides temperature-controlled road transport and logistics services for agri-food industry. It transports fresh, frozen, and temperature sensitive products; and seafood products. The company also provides co-packing and manufacturing services; and out-of-home food services. It operates in ... STEF SA provides temperature-controlled road transport and logistics services for agri-food industry. It transports fresh, frozen, and temperature sensitive products; and seafood products. The company also provides co-packing and manufacturing services; and out-of-home food services. It operates in France, Italy, Spain, Portugal, Belgium, the Netherlands, Switzerland, and the United Kingdom. The company was founded in 1920 and is headquartered in Paris, France. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.stef.com

本社

Paris, France

設立

2026

Stef is listed in the sector of the ロンドン証券取引所 with ticker 0NY3. The last closing price for Stef was 110.20 €. Over the last year, Stef shares have traded in a share price range of 110.20 € to 110.20 €.

Stef currently has 12,649,263 shares in issue. The market capitalisation of Stef is 1.39 € billion. Stef has a price to earnings ratio (PE ratio) of 17.72.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	110.2	110.2	110.2	73	110.2	DE
52	0	0	110.2	110.2	110.2	32	110.2	DE
156	0	0	110.2	110.2	110.2	45	110.2	DE
260	0	0	110.2	110.2	110.2	151	110.2	DE

0NY3 - Frequently Asked Questions (FAQ)

What is the current Stef share price?

The current share price of Stef is 110.20 €

How many Stef shares are in issue?

Stef has 12,649,263 shares in issue

What is the market cap of Stef?

The market capitalisation of Stef is EUR 1.39B

What is the 1 year trading range for Stef share price?

Stef has traded in the range of 110.20 € to 110.20 € during the past year

What is the PE ratio of Stef?

The price to earnings ratio of Stef is 17.72

What is the cash to sales ratio of Stef?

The cash to sales ratio of Stef is 0.29

What is the registered address of Stef?

The registered address for Stef is 93, Boulevard Malesherbes, Paris, Ile-de-France, 75008

What is the Stef website address?

The website address for Stef is www.stef.com

DangFool

DangFool 5分前

I thought their failure to make annual filings was was put it on the Pink Sheets in the first place.

Anyway, it seems they're willing to leave the Pink Sheets a no-man's land of massive fraud.

Wanted to point out that I was wrong before when I said Foley'd been acquitte

shajandr

shajandr 22分前

My genetic progenitors dint arrive in the USA until more than a hunnert years after 1776. I am only a fourth and fifth generation Merrikun. Hell, I'm still trying to learn the langwitch.

https://investorshub.advfn.com/uimage/uploads/2026/7/5/aktqwPolish-Immigrants.png
https://i

lakers17

lakers17 23分前

Yamamoto 7 scoreless as Dodgers beat San Diego again and win 3-0 to go 59-31 and go up 15 on the Padres. Sheehan pitches on Sunday maybe the weakest Dodger starter. Dodgers keep winning with Glasgow and Snell out.

muee88

muee88 25分前

True. But logic says that the probability is slim that this data hasn’t already been submitted to MHRA.

satter

satter 25分前

Is that possible? Asking that of someone who writes to the SEC authority a complaint with blame with containing no evidence of it.

gfp927z

gfp927z 38分前

More on the new US national Stablecoin, as well as the Fed's plan to gradually 'inflate away' the US national debt -

(see 10:00 - 15:00) -

https://youtu.be/Y4FSMYSt2zQ

---

gfp927z

gfp927z 38分前

US Stablecoin consortium -

A huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is lik

gfp927z

gfp927z 40分前

More on the new US national Stablecoin, as well as the Fed's plan to gradually 'inflate away' the US national debt -

(see 10:00 - 15:00) -

https://youtu.be/Y4FSMYSt2zQ

---

gfp927z

gfp927z 42分前

More on the new US national Stablecoin, as well as the Fed's plan to gradually 'inflate away' the US national debt -

(see 10:00 - 15:00) -

https://youtu.be/Y4FSMYSt2zQ

---

gfp927z

gfp927z 47分前

US Stablecoin consortium -

A huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is lik

gfp927z

gfp927z 50分前

Bigworld, It looks like a huge development last week for the coming US national Stablecoin system. 140 of the biggest players in finance are forming a consortium to run and own the new US digital dollar / stablecoin system they call 'Open US' (links below). The stablecoin is like a CBDC (digital

Twiggs333

Twiggs333 1時間前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 1時間前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 1時間前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 1時間前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

OMOLIVES

OMOLIVES 1時間前

Happy Fourth of July to all!...and a big thank you to the French. Vive la France!:

https://x.com/Phoenix2A_1980s/status/2073453266428387385

4u2nv2

4u2nv2 1時間前

Every filing from the time Paul and Ben took over said there were 3 preferred shareholders. The third one was never named. Now, it's interesting to question how Newby got controlling interest when we do not know all of the facts concerning what Ben really wanted to accomplish with taking on the comm

Eli's Gone

Eli's Gone 1時間前

I'm in: 11-5-24-19

Eli's Gone

Eli's Gone 1時間前

gfp927z

gfp927z 2時間前

>>> Look At Who Joined Open USD To Understand Where Money Is Going

Forbes

by Zennon Kapron

Jul 02, 2026

https://www.forbes.com/sites/digital-assets/2026/07/02/look-at-who-joined-open-usd-to-understand-where-money-is-going/

Sammy boy

Sammy boy 2時間前

Said it 4 months ago Bessent is the problem ! There is a reason he cold-cocked Tommy Boy.

misterfishman

misterfishman 2時間前

Me too my side hobbies are researching new forms of energy from the enviroment,been at this for more than 20 yrs now and have accumilated a great deal oh knowledge.

Atlanta1

Atlanta1 2時間前

Joey - Why do you waste time on this lunatic?

FeMike

FeMike 2時間前

The original randomised primary endpoint (PFS) was negative and showed harm,

The simple fact that you don’t understand pseudo progression is more than enough to establish as also fact that you have no idea what you’re talking about.

Altech Chemicals

Elinoil Hellenic Petroleum

Housing Australia

Wcm International Equity...

High Dividend Equity Por...

Norwood Systems

Jpmorgan Betabuilders Ca...

Prosoft Learning

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。